Importance of protocols for simulation studies in clinical drug development. - Wikidata - awgldk - TriplyDB

Importance of protocols for simulation studies in clinical drug development.

Importance of protocols for simulation studies in clinical drug development.

http://www.wikidata.org/entity/Q37778184

about

Optimizing drug development in oncology by clinical trial simulation: Why and how?Statistical challenges in assessing potential efficacy of complex interventions in pilot or feasibility studies.Statistical issues in drug development.Sample size and classification error for Bayesian change-point models with unlabelled sub-groups and incomplete follow-up.Simulation-based sample-sizing and power calculations in logistic regression with partial prior information.Use of statistical and pharmacokinetic-pharmacodynamic modeling and simulation to improve decision-making: A section summary report of the trends and innovations in clinical trial statistics conference.Proposed best practice for projects that involve modelling and simulation.

P2860

Q38675644-714FB331-5D1A-4A41-A8A1-9856C71328E3 Q40838999-8BD0FADA-1B54-4F15-B5CC-5EE3DD8F2A0C Q44557252-2207AAD0-B0D5-4F44-AB05-477FF71D2DB4 Q47282507-94E18EDF-2A43-4DA6-82D3-E1D5528A75CE Q48372811-7BF766BB-94E5-43FC-B462-E2A88249C873 Q50673342-900B9041-CAC5-4F7A-A9A9-334EB5C92036 Q52841716-BC607DD0-88AC-44D9-A9D4-B704B78428F8

P2860

Importance of protocols for simulation studies in clinical drug development.

http://www.wikidata.org/entity/Q37778184

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 05 August 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Importance of protocols for simulation studies in clinical drug development.

@en

Importance of protocols for simulation studies in clinical drug development.

@nl

type

label

Importance of protocols for simulation studies in clinical drug development.

@en

Importance of protocols for simulation studies in clinical drug development.

@nl

prefLabel

Importance of protocols for simulation studies in clinical drug development.

@en

Importance of protocols for simulation studies in clinical drug development.

@nl

P1433

Q37778184-BB7AEDB0-A8BD-4F71-8407-0D88A728C16A

P1476

Q37778184-BB1DBB83-6617-4A2C-824E-10224A08BA32

P2093

Q37778184-05ADC561-DEBE-47B0-9952-6C12E345A8EC

Q37778184-CC7B40A7-F22F-496D-81DE-3B67DFE0A7C1

P2860

Q37778184-38F5F038-315A-4752-92D6-D957EF234BF9

Q37778184-459CE4CD-7FE3-4EF6-AAA4-DA9E40D7957A

Q37778184-492324A5-FD1E-41B4-8510-337E51F65BF7

Q37778184-85B6A8D3-82F1-4FF4-A73E-C22477B7F20A

Q37778184-908F06C2-AAC9-4F08-99A1-977EC3754329

Q37778184-9F8CDBFD-7F93-4568-9229-D82A29708EF2

Q37778184-AA30F51A-A79D-49FB-A57F-0B1931371DA6

Q37778184-BA61273A-D090-4B2D-9F4D-ADF314E55744

Q37778184-BE5B540B-1014-4A50-A75E-33FE84150EAA

Q37778184-CC7278BE-C8C2-417E-BEBB-42FA23F9B8B6

P304

Q37778184-7DC173A9-B4CC-4C5A-960A-24071E13D064

P31

Q37778184-5819CE90-BDF9-43C7-8D83-C4BC357C79C9

P356

Q37778184-CEAA6EEF-AAED-4D7B-8BC2-EED5C9B022A5

P433

Q37778184-636D7E4C-F4BC-4D62-BDCA-B9DB69E8AB0E

P478

Q37778184-A87668AE-961E-4CF5-A668-8A15F7ED6CF0

P577

Q37778184-558D6A42-C0A5-41E3-9AEC-7FEA1F812788

P698

Q37778184-F9B1D9CC-6E65-4885-A83C-78DA474B05B0

P356

0962280210378949

P1433

Statistical Methods in Medical Research

P1476

Importance of protocols for simulation studies in clinical drug development.

@en

P2093

Andrea Marshall

http://www.w3.org/2001/XMLSchema#string

Mike K Smith

http://www.w3.org/2001/XMLSchema#string

P2860

Simulation of clinical trials.

Clinical trial simulation: a tool for understanding study failures and preventing them.

Pharmacokinetics/Pharmacodynamics and the stages of drug development: role of modeling and simulation.

The design of simulation studies in medical statistics.

Model-based drug development.

Modeling and simulation to support dose selection and clinical development of SC-75416, a selective COX-2 inhibitor for the treatment of acute and chronic pain.

Application of an adaptive design to a randomized phase II selection trial in gastric cancer: a report of the study design.

Clinical trials simulation: a statistical approach.

Implementation of a Bayesian adaptive design in a proof of concept study.

A Bayesian design and analysis for dose-response using informative prior information.

P304

613-622

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0962280210378949

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P577

2010-08-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20688782

http://www.w3.org/2001/XMLSchema#string